A multicentre prospective cohort study of immune function in patients treated with monoclonally immunopurified or resin-purified SNBTS high-potency factor VIII concentrate.
Hay
C R
CR
Department of Haematology, Manchester Royal Infirmary, U.K.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications / Q000276:immunology*; D000911:Antibodies, Monoclonal; D015331:Cohort Studies; D005169:Factor VIII / Q000276:immunology* / Q000302:isolation & purification / Q000627:therapeutic use; D006467:Hemophilia A / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D007163:Immunosorbent Techniques / Q000009:adverse effects*; D007164:Immunosorbents / Q000009:adverse effects* / Q000276:immunology; D011446:Prospective Studies; D012116:Resins, Plant
D000911:Antibodies, Monoclonal; D007164:Immunosorbents; D012116:Resins, Plant; D005169:Factor VIII